Mycobacterial Diseases
Open Access

Haruaki Tomioka

Biography

I am the professor of Department of Microbiology and Immunology，Shimane University School of Medicine, Izumo, Japan. I am acting or have ever acted as a director of Japanese Society for Bacteriology, Japanese Association for Infectious Diseases, and Japanese Society for Tuberculosis, and presently acting as a district leader of these three academic societies in the western part of Japan. I am also an associate editor of three international journals, “Microbiology and Immunology”, “Journal of Infection and Chemotherapy”, and “Chemotherapy Research and Practice”. I am acting or have ever acted as the reviewers for the following journals: J Infect Dis, Infect Immun, Antimicrob Agents Chemother, J Antimicrob Chemother, Int J Antimicrob Agents, Clin Exp Immunol, Future Microbiol, Biochim Biophys Acta, J Med Microbiol, Cell Mol Biol, FEMS Microb Lett, Expert Opin Pharmacol, Expert Opin Invest Drugs, BMC Infect Dis, Lung, J Pharm Pharmacol, etc. In addition, I have ever acted as an executive editor of Curr Pharm Des (IF=5.3) and edited the special issue entitled “Antimycobacterial Drugs: Current Status and Future Prospects”. I have also acted as an editor of the special immunology book entitled “Current Topics on the Profiles of Host Immunological Responses to Mycobacterial Infections”, which was published by Research Signpost. I have published more than 250 scientific articles in peer reviewed international journals and medical book chapters.

Research Interest

I am the professor of Department of Microbiology and Immunology，Shimane University School of Medicine, Izumo, Japan. I am acting or have ever acted as a director of Japanese Society for Bacteriology, Japanese Association for Infectious Diseases, and Japanese Society for Tuberculosis, and presently acting as a district leader of these three academic societies in the western part of Japan. I am also an associate editor of three international journals, “Microbiology and Immunology”, “Journal of Infection and Chemotherapy”, and “Chemotherapy Research and Practice”. I am acting or have ever acted as the reviewers for the following journals: J Infect Dis, Infect Immun, Antimicrob Agents Chemother, J Antimicrob Chemother, Int J Antimicrob Agents, Clin Exp Immunol, Future Microbiol, Biochim Biophys Acta, J Med Microbiol, Cell Mol Biol, FEMS Microb Lett, Expert Opin Pharmacol, Expert Opin Invest Drugs, BMC Infect Dis, Lung, J Pharm Pharmacol, etc. In addition, I have ever acted as an executive editor of Curr Pharm Des (IF=5.3) and edited the special issue entitled “Antimycobacterial Drugs: Current Status and Future Prospects”. I have also acted as an editor of the special immunology book entitled “Current Topics on the Profiles of Host Immunological Responses to Mycobacterial Infections”, which was published by Research Signpost. I have published more than 250 scientific articles in peer reviewed international journals and medical book chapters.